TTM
$687M
YoY change
+3.8%
5Y CAGR
+8.1%
Peak year (FY2022)
$764M
Cumulative operating income
$7.38B
Operating Income history chart for West Pharmaceutical Services (WST) from 2016 to 2025
Latest: $617M
Operating Income growth chart for West Pharmaceutical Services (WST) from 2016 to 2025
Latest: +3.8%
Operating Income history table for West Pharmaceutical Services (WST) from 1985 to 2025
| FY2025 | $617M | +3.8% | +$22.8M | ||
| FY2024 | $595M | -16.4% | -$116M | ||
| FY2023 | $711M | -6.9% | -$52.6M | ||
| FY2022 | $764M | +0.6% | +$4.8M | ||
| FY2021 | $759M | +81.1% | +$340M | ||
| FY2020 | $419M | +41.0% | +$122M | ||
| FY2019 | $297M | +16.6% | +$42.4M | ||
| FY2018 | $255M | +10.9% | +$25.1M | ||
| FY2017 | $230M | +6.6% | +$14.2M | ||
| FY2016 | $216M | +71.4% | +$89.8M | ||
| FY2015 | $126M | -30.9% | -$56.2M | ||
| FY2014 | $182M | +16.1% | +$25.2M | ||
| FY2013 | $157M | +14.8% | +$20.2M | ||
| FY2012 | $137M | +17.8% | +$20.6M | ||
| FY2011 | $116M | +9.3% | +$9.9M | ||
| FY2010 | $106M | 0.0% | $0.00 | ||
| FY2009 | $106M | -14.9% | -$18.6M | ||
| FY2008 | $125M | +10.3% | +$11.6M | ||
| FY2007 | $113M | +6.9% | +$7.3M | ||
| FY2006 | $106M | +44.4% | +$32.5M | ||
| FY2005 | $73.2M | +14.6% | +$9.3M | ||
| FY2004 | $63.9M | +17.2% | +$9.4M | ||
| FY2003 | $54.5M | +104.1% | +$27.8M | ||
| FY2002 | $26.7M | -35.4% | -$14.6M | ||
| FY2001 | $41.3M | +15.7% | +$5.6M | ||
| FY2000 | $35.7M | -46.2% | -$30.7M | ||
| FY1999 | $66.4M | +2.6% | +$1.7M | ||
| FY1998 | $64.7M | +4.5% | +$2.8M | ||
| FY1997 | $61.9M | +16.1% | +$8.6M | ||
| FY1996 | $53.3M | +10.4% | +$5M | ||
| FY1995 | $48.3M | +2.5% | +$1.2M | ||
| FY1994 | $47.1M | +14.6% | +$6M | ||
| FY1993 | $41.1M | +3.5% | +$1.4M | ||
| FY1992 | $39.7M | -3153.8% | +$41M | ||
| FY1991 | -$1.3M | -106.1% | -$22.5M | ||
| FY1990 | $21.2M | -41.3% | -$14.9M | ||
| FY1989 | $36.1M | +18.8% | +$5.7M | ||
| FY1988 | $30.4M | +1.7% | +$500K | ||
| FY1987 | $29.9M | -2.9% | -$900K | ||
| FY1986 | $30.8M | +31.1% | +$7.3M | ||
| FY1985 | $23.5M | — | — |
- FY2025$617M+3.8%
- FY2024$595M-16.4%
- FY2023$711M-6.9%
- FY2022$764M+0.6%
- FY2021$759M+81.1%
- FY2020$419M+41.0%
- FY2019$297M+16.6%
- FY2018$255M+10.9%
- FY2017$230M+6.6%
- FY2016$216M+71.4%
- FY2015$126M-30.9%
- FY2014$182M+16.1%
- FY2013$157M+14.8%
- FY2012$137M+17.8%
- FY2011$116M+9.3%
- FY2010$106M0.0%
- FY2009$106M-14.9%
- FY2008$125M+10.3%
- FY2007$113M+6.9%
- FY2006$106M+44.4%
- FY2005$73.2M+14.6%
- FY2004$63.9M+17.2%
- FY2003$54.5M+104.1%
- FY2002$26.7M-35.4%
- FY2001$41.3M+15.7%
- FY2000$35.7M-46.2%
- FY1999$66.4M+2.6%
- FY1998$64.7M+4.5%
- FY1997$61.9M+16.1%
- FY1996$53.3M+10.4%
- FY1995$48.3M+2.5%
- FY1994$47.1M+14.6%
- FY1993$41.1M+3.5%
- FY1992$39.7M-3153.8%
- FY1991-$1.3M-106.1%
- FY1990$21.2M-41.3%
- FY1989$36.1M+18.8%
- FY1988$30.4M+1.7%
- FY1987$29.9M-2.9%
- FY1986$30.8M+31.1%
- FY1985$23.5M—
Operating Income values are taken from West Pharmaceutical Services's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Income at West Pharmaceutical Services (WST)
According to West Pharmaceutical Services's latest reported financial statements, the company's current operating income (TTM) is $687M. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of West Pharmaceutical Services (WST) operating income is $617M – edged up 3.8% year-over-year.
West Pharmaceutical Services operating income has grown on net over the period, with a +8.1% compound annual growth rate over 2020–2025 (5 years).
West Pharmaceutical Services operating income declined from $764M in 2022 to $617M in 2025, a 19.1% drawdown.
$764M stands as the all-time-high annual operating income, posted in 2022, against a low of -$1.3M during 1991.
West Pharmaceutical Services Operating Income by Year
West Pharmaceutical Services Operating Income 2025: $617M
West Pharmaceutical Services operating income in 2025 was $617M, edged up 3.8% from 2024.
West Pharmaceutical Services Operating Income 2024: $595M
2024's operating income for West Pharmaceutical Services came in at $595M, declined 16.4% below 2023.
West Pharmaceutical Services Operating Income 2023: $711M
West Pharmaceutical Services posted operating income of $711M in 2023, declined 6.9% below 2022.
West Pharmaceutical Services Operating Income 2022: $764M
In 2022, West Pharmaceutical Services reported operating income of $764M, edged up 0.6% from 2021. This figure represents the highest annual value in the available history.
West Pharmaceutical Services Operating Income 2021: $759M
West Pharmaceutical Services operating income in 2021 was $759M.
See more financial history for West Pharmaceutical Services (WST).
Sector peers by Operating Income
Healthcare peers of West Pharmaceutical Services (WST), ranked by their latest operating income
| $29.7B | |
| $25.6B | |
| $23.5B | |
| $20.1B | |
| $19.9B | |
| $19B | |
| $10.7B | |
| $8.11B |
- $29.7B
- $25.6B
- $23.5B
- $20.1B
- $19.9B
- $10.7B
Frequently asked questions
West Pharmaceutical Services (WST) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks2.34% TTM
- Dividend Profile0.32% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History4 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.